Daniele Gabriel-Costa Selected Research

LASSBio 294

1/2017

Adenosine A2A receptor agonist prevents cardiac remodeling and dysfunction in spontaneously hypertensive male rats after myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniele Gabriel-Costa Research Topics

Disease

3	Heart Failure 07/2017 - 01/2016
2	Hypertension (High Blood Pressure) 07/2017 - 01/2017
2	Fibrosis (Cirrhosis) 01/2017 - 03/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017
1	Myocardial Infarction 01/2017
1	Overnutrition 03/2016
1	Body Weight (Weight, Body) 03/2016
1	Cardiomegaly (Heart Hypertrophy) 03/2016
1	Hyperglycemia 03/2016
1	Hyperinsulinism (Hyperinsulinemia) 03/2016
1	Obesity 03/2016
1	Muscular Diseases (Myopathy) 01/2016
1	Sudden Death 01/2016

Drug/Important Bio-Agent (IBA)

1	Estrogens (Estrogen)FDA Link 07/2017
1	LASSBio 294IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	CollagenIBA 01/2017
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2017
1	CarbohydratesIBA 03/2016
1	Insulin (Novolin)FDA Link 03/2016
1	Liver GlycogenIBA 03/2016
1	Messenger RNA (mRNA)IBA 03/2016
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2016
1	beta-Aminoethyl Isothiourea (AET)IBA 01/2016

Therapy/Procedure

1	Oral Administration 01/2017
1	Therapeutics 01/2016